Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
crushresearch.shop
Samples
Passed
Failed
Trust score updated: May 28, 2026 · 100% pass rate
Composite score based on 53 COAs attributed to this vendor.
Mean HPLC purity across published COAs
Per-peptide coverage of identity / endotoxin / microbial / heavy-metals / net-content panels
Lab corroboration tier — confirmed via public verify portal (90), presumptive trusted lab (85), lab resolved but unverified (75), or no lab attribution (50)
Inverse of CoaFlag count (lot collisions, hash collisions, etc.)
Composite of 53 COAs attributed to this vendor. Last recomputed 2026-05-28.
Research peptide vendor. COAs (/testing) are gated behind a customer login; we cannot index them without account access.
| Date | Peptide | Test | Result | Purity | Lab | Notes |
|---|---|---|---|---|---|---|
| May 11, 2026 | PT-141 | HPLC purity | PASS | 99.93% | ILS Labs | Lot CRPT-10-2605-1 · Report ACC-2026-2067 |
| May 11, 2026 | NAD+ | HPLC purity | PASS | 99.44% | ILS Labs | Lot CR-NJ500-0309-1 · Report ACC-2026-2070 |
| May 11, 2026 | MOTS-c | HPLC purity | PASS | 99.91% | ILS Labs | Lot CR-MTS10-0309-1 · Report ACC-2026-2076 |
We are continuously testing more products. Scores update with each new result.
Read our scoring methodology →Trust scores are computed from indexed Certificates of Analysis — vendor-published, and lab-confirmed where a lab copy verifies them — using a fixed, versioned methodology (v13). They are not based on independent blind-purchase testing, and no vendor can pay for placement or a higher score. How we score · How we make money
PMB address (-0.03), New domain (-0.06), Full identity on file (0.03), Lab-confirmed (0.02)
Sources: RDAP/WHOIS for domain data, Twilio Lookup for phone classification, Google Places for address verification. Crawl runs weekly. Signals are independent of vendor-supplied data.
| May 11, 2026 | Tesamorelin | HPLC purity | PASS | 99.47% | ILS Labs | Lot CR-TSM20-0307-1 · Report ACC-2026-2073 |
| May 11, 2026 | EPITALON | HPLC purity | PASS | 99.08% | ILS Labs | Lot CRET-50-0212-1 · Report ACC-2026-2079 |
| Apr 22, 2026 | NAD 500mg | HPLC purity | PASS | 99% | ILS Labs | Lot CRNAD-500-2604-2 · Report ACC-2026-0953 |
| Apr 22, 2026 | Klow | HPLC purity | PASS | 99.47% | ILS Labs | Lot CRKLO-80-2604-1 · Report ACC-2026-0943 |
| Apr 22, 2026 | Double Agonist | HPLC purity | PASS | 99.95% | ILS Labs | Lot CRTZ-30-2604-1 · Report ACC-2026-0937 |
| Apr 22, 2026 | Double Agonist | HPLC purity | PASS | 99.95% | ILS Labs | Lot CRTZ-30-2604-2 · Report COA-2026-STQCRC |
| Apr 22, 2026 | KPV | HPLC purity | PASS | 99.36% | ILS Labs | Lot CRKPV-10-2604-1 · Report ACC-2026-0949 |
| Apr 22, 2026 | GHK-Cu | HPLC purity | PASS | 99.91% | ILS Labs | Lot CRGHK-100-2604-1 · Report ACC-2026-0951 |
| Apr 22, 2026 | Cagrilintide | HPLC purity | PASS | 99.69% | ILS Labs | Lot CRCAG-5-2604-1 · Report ACC-2026-0947 |
| Apr 22, 2026 | Triple Agonist | HPLC purity | PASS | 99.92% | ILS Labs | Lot CRRT-30-2604-2 · Report ACC-2026-0955 |
| Apr 22, 2026 | VIP | HPLC purity | PASS | 99.46% | ILS Labs | Lot CRVIP-10-2604-1 · Report ACC-2026-0941 |
| Apr 4, 2026 | Retatrutide | HPLC purity | PASS | 99.61% | ILS Labs | Lot CR-3XAG14-2604-1 · Report COA-2026-C6JTW5 |